header
Image from OpenLibrary

Effect of Zinc in management of the common cold in Elderly / Amira Abdelhamid Mohammad Abdelate ; Supervised Lubna Mohammad Anas Fawaz , Dalia Ahmed Mohamed , Ghada Mahmoud Khafajy

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Amira Abdelhamid Mohammad Abdelate , 2016Description: 95 P. : charts ; 25cmOther title:
  • تأثير الزنك في علاج نزلات البرد لدي المسنين [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Family Medicine Summary: Background: The common cold is the most commonly encountered infectious disease of human beings, and the most frequent illness managed in general Practice. The essentiality of zinc and its deficiency in humans were recognized in the early 1960s. Dietary zinc intake declines with advancing age. Zinc is involved in the immune response to infection and inhibits rhinovirus replication in vitro led to the proposal of zinc as a treatment for the common cold.Objective: To study the effect of zinc on the severity, duration of symptoms and incidence of complications of common cold in elderly (>60years). Patients and methods: This study was a prospective, interventional, single blind, placebo controlled study in elderly (>60years) of any symptom of common cold. 106 patients were randomized from elderly homes to take either zinc capsules or placebo for maximally 7 days. The median IQR of total symptom scoring in day 3 and 5 was compared between the two groups. Results: The reduction in total symptom scoring from baseline in day 5 was significantly greater in zinc group than in placebo group. Nasal discharge, sneezing, cough, fever and muscle ache, resolved faster in zinc group (3-5days) than in placebo group (5-7days). There was (15%) of patients in zinc group need to use antibiotic for secondary bacterial infection, while in placebo group the percent was (32%). Conclusion: Zinc is helpful in reducing the duration and severity of common cold symptoms in elderly and decrease the incidence of complication with no adverse effects
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.35.M.Sc.2016.Am.E (Browse shelf(Opens below)) Not for loan 01010110070519000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.35.M.Sc.2016.Am.E (Browse shelf(Opens below)) 70519.CD Not for loan 01020110070519000

Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Family Medicine

Background: The common cold is the most commonly encountered infectious disease of human beings, and the most frequent illness managed in general Practice. The essentiality of zinc and its deficiency in humans were recognized in the early 1960s. Dietary zinc intake declines with advancing age. Zinc is involved in the immune response to infection and inhibits rhinovirus replication in vitro led to the proposal of zinc as a treatment for the common cold.Objective: To study the effect of zinc on the severity, duration of symptoms and incidence of complications of common cold in elderly (>60years). Patients and methods: This study was a prospective, interventional, single blind, placebo controlled study in elderly (>60years) of any symptom of common cold. 106 patients were randomized from elderly homes to take either zinc capsules or placebo for maximally 7 days. The median IQR of total symptom scoring in day 3 and 5 was compared between the two groups. Results: The reduction in total symptom scoring from baseline in day 5 was significantly greater in zinc group than in placebo group. Nasal discharge, sneezing, cough, fever and muscle ache, resolved faster in zinc group (3-5days) than in placebo group (5-7days). There was (15%) of patients in zinc group need to use antibiotic for secondary bacterial infection, while in placebo group the percent was (32%). Conclusion: Zinc is helpful in reducing the duration and severity of common cold symptoms in elderly and decrease the incidence of complication with no adverse effects

Issued also as CD

There are no comments on this title.

to post a comment.